Anna Gottschlich News Today

HPV testing eight years after negative result was comparable to risk after three years in cytology cohort

A 5-year interval between cervical cancer screenings using HPV testing does not increase risk for cervical precancer detection compared with cytology every 3 years and may be a more effective screening method long term, researchers report.The U.S. has gradually transitioned from cytology to HPV-based screening for cervical cancer over the past 20 years, according to Anna Gottschlich, PhD, MPH,

HPV testing to prevent cervical cancer might not have to happen as often as currently recommended, a new study says.

Over the past two decades, the United States has been transitioning from cytology to HPV-based screening for cervical cancer. The U.S. Preventive Services Task Force currently recommends one of three options for routine cervical cancer screening: 1) cytology screening every three years; 2) HPV screening every five years; or 3) co-testing in which both an HPV and cytology screening are conducted every five years.